Cargando…
Cellular protoonocogenes are infrequently amplified in untreated non-small cell lung cancer.
To examine a potential contribution of protooncogene abnormalities other than point-mutational activation of the K-ras protooncogene in the classification of non-small cell lung cancer, amplification of cellular protooncogenes was studied in 47 lung tumour specimens obtained at thoracotomy and in fo...
Autores principales: | Slebos, R. J., Evers, S. G., Wagenaar, S. S., Rodenhuis, S. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1989
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2246978/ https://www.ncbi.nlm.nih.gov/pubmed/2547415 |
Ejemplares similares
-
Cellular Landscaping of COVID-19 and Gynaecological Cancers: An Infrequent Correlation
por: Bhattacharjee, Rahul, et al.
Publicado: (2022) -
Monitoring Circulating Tumor DNA in Untreated Non-Small-Cell Lung Cancer Patients
por: Ryu, Woo Kyung, et al.
Publicado: (2022) -
MEK inhibitors against MET-amplified non-small cell lung cancer
por: Chiba, Masato, et al.
Publicado: (2016) -
Infrequent microsatellite instability in oesophageal cancers.
por: Muzeau, F., et al.
Publicado: (1997) -
Pembrolizumab for Previously Untreated Patients with Advanced Non-small-cell Lung Cancer and Preexisting Interstitial Lung Disease
por: Fujita, Tetsuo, et al.
Publicado: (2020)